Key facts
- Azalea Vision’s last known valuation is $20.0M (Apr 2025).
- It has raised $19.3M; the latest was Later Stage VC ($10.0M) in Apr 2025.
- Notable investors include European Innovation Council, Elaia Partners, SPRIM Global Investments, Sensinnovat, European Innovation Council (Belgium) — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Azalea Vision
- ·The full record, as it builds
Funding rounds
No funding rounds for Azalea Vision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Azalea Vision
Developer of a smart contact lens technology designed to address various vision disorders. The company's technology offers adaptive, non-invasive features designed to treat conditions like keratoconus, presbyopia and photophobia by combining comfort and discretion for users, enabling individuals with vision challenges to experience clear, bright and accessible eye services for improved daily life.
- Sector
- Healthcare
- HQ
- Ghent, Belgium
- Founded
- 2020
- Employees
- 12
- Website
- azaleavision.com/
- Ownership
- Privately Held (backing)
Azalea Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Azalea Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Azalea Vision in its N-PORT filings yet. We sweep new filings monthly.